President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
February Jobs Report Shows Resilient Economy, Says White House Economic Adviser
About 678,000 jobs were created in February, hundreds of thousands more than predicted, according to the latest Labor Department report, showing a broad economic recovery despite inflation woes. Heather Boushey, member of the Council of Economic Advisers for President Biden, joined Cheddar News to talk about the employment figures. "This really shows that the economy is now more resilient because of the tools that we have in place," Boushey said. "So I'm optimistic that we'll be able to weather future storms."
How Ketanji Brown Jackson's SCOTUS Nomination Came to Be
Tyler Pager, White House reporter at the Washington Post, and Reecie Colbert, founder of BlackWomenViews Media, join Cheddar Politics to discuss President Biden's Supreme Court nominee Judge Ketanji Brown Jackson. They break down how her nomination came to be and what comes next in her confirmation process.
Russia, Ukraine Hold Second Round of Talks
Joel Rubin, former deputy assistant at Secretary of State & president of the Washington Strategy Group, joins Cheddar News to break down the latest between Russia and Ukraine.
Breaking Down the State of the Union
Nicole Goodkind, business and politics reporter at Fortune Magazine, joins Cheddar Politics to break down President Biden's first State of the Union address.
Load More